A Phase 1 Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of EU103 in Advanced or Metastatic Solid Tumors That Have Failed Standard Therapy
Clinical trial NCT05798026 · UNKNOWN
Trial details
- NCT number
- NCT05798026
- Sponsor
- Eutilex
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-08
- Primary completion
- 2025-04-30
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.